|
|
 |
|
Viewing report
|
|
|
|
Therapeutic Strategies in Pulmonary Arterial Hypertension
Clinical Publishing, April 2009, Pages: 112
Pulmonary arterial hypertension (PAH) is a rare condition; yet this very rarity can be a disadvantage when it comes to treatment, making PAH difficult to diagnose, and resulting in suboptimal patient care. Furthermore, the global burden of PAH remains poorly understood and largely underestimated, as PAH commonly presents as a comorbidity with such conditions as systemic sclerosis, COPD, idiopathic pulmonary fibrosis and left-heart dysfunction. However, in recent years there has been significant investment in developing new therapies for PAH, and treatment for this previously neglected disease is set to enter a new era. This new work draws on the recent published literature and clinical trials to review the latest developments in our understanding of the disease, new advances in therapy and current opinion on best practice approaches to management. Internationally-recognised authorities on PAH provide expert analysis of these advances and critical commentary on the data presented to help explain the implications of these findings for future clinical practice.
Benefits:
- Presents a comprehensive review of current treatment options in this complex field
- Covers primary research and future developments in addition to current practice and the latest trials
Readership:
- Pulmonologists and respiratory specialists
- Cardiologists
- Internal medicine physicians
- Hospital pharmacists
- Doctors in training
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Pulmonary Hypertension
Stakeholder Opinions: Pulmonary Arterial Hypertension clinical community builds order from chaos
Embolic Protection Devices (EPD) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Cardiac Prosthetic Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Global Embolic Protection Devices (EPD) - Market Growth Analysis, 2009-2015
Pulmonary Arterial Hypertension: Diagnosis and Evidence-Based Treatment
Electrophysiology (EP) Ablation Catheters - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Diagnostic Electrophysiology Catheters - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Cardiac Defibrillators - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
|
|
|
|
